Alnylam Pharmaceuticals (ALNY) EPS (Basic) (2009 - 2026)
Alnylam Pharmaceuticals' (ALNY) quarterly EPS (Basic) came in at $1.23 in Q2 2026, up 322.67% YoY from $0.29 in Q2 2025, and down 20.57% on a QoQ basis from $1.55 in Q1 2026.
Alnylam Pharmaceuticals (ALNY) EPS (Basic) (2009 - 2026) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has 18 years of EPS (Basic) data on file, last reported at $1.23 in Q2 2026.
- Quarterly EPS (Basic) rose 322.67% year-over-year to $1.23 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.8 (up 365.01% YoY) and the FY2025 annual result came in at $2.39, up 209.91% from the prior year.
- EPS (Basic) declined to $1.23 in Q2 2026, from $1.55 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.23 in Q3 2025 to a low of -$3.32 in Q3 2022.
- A 5-year average of -$0.55 and a median of -$0.6 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2025 — EPS (Basic) sank 314.91% — and 2026, when it surged 1201.33%.
- Tracing ALNY's EPS (Basic) over 5 years: stood at -$1.71 in 2022, then surged by 35.27% to -$1.1 in 2023, then soared by 40.55% to -$0.66 in 2024, then surged by 229.76% to $0.85 in 2025, then soared by 44.6% to $1.23 in 2026.
- The last three EPS (Basic) figures came in at $1.23 (Q2 2026), $1.55 (Q1 2026), and $0.85 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -0.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.23 |
| Mar 31, 2026 | 1.55 |
| Dec 31, 2025 | 0.85 |
| Sep 30, 2025 | 2.23 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.66 |
| Sep 30, 2024 | -0.87 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.52 |
| Dec 31, 2023 | -1.10 |
| Sep 30, 2023 | 1.18 |
| Jun 30, 2023 | -2.21 |
| Mar 31, 2023 | -1.40 |
| Dec 31, 2022 | -1.71 |
| Sep 30, 2022 | -3.32 |
| Jun 30, 2022 | -2.29 |
| Mar 31, 2022 | -2.00 |
| Dec 31, 2021 | -2.18 |
| Sep 30, 2021 | -1.72 |